ReviewJournal of oncology2019

Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements towards New Perspectives.

Diego De Goycoechea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.